Evidence map›Paper›PMID 25273567›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2014

Genetic deletion of LXRα prevents arsenic-enhanced atherosclerosis, but not arsenic-altered plaque composition.

Maryse Lemaire, Catherine A Lemarié, Manuel Flores Molina, Cynthia Guilbert, Stéphanie Lehoux, Koren K Mann

Open access · bronzeAbstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Maryse Lemaire*Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2 *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2.
Catherine A Lemarié*Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2 *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2.
Manuel Flores Molina*Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2.
Cynthia Guilbert*Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2.
Stéphanie Lehoux*Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2 *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2.
Koren K Mann*Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2 *Department of Oncology, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montréal, Canada H3T 1E2 koren.mann@mcgill.ca.
McGill University · CA

Funding

Canadian Institutes of Health Research MFE-120914Canadian Institutes of Health Research MOP-102498Canadian Institutes of Health Research MOP-115000
6 · The paper itself

Abstract

Arsenic exposure has been linked to an increased incidence of atherosclerosis. Previously, we have shown in vitro and in vivo that arsenic inhibits transcriptional activation of the liver X receptors (LXRs), key regulators of lipid homeostasis. Therefore, we evaluated the role of LXRα in arsenic-induced atherosclerosis using the apoE(-/-) mouse model. Indeed, deletion of LXRα protected apoE(-/-) mice against the proatherogenic effects of arsenic. We have previously shown that arsenic changes the plaque composition in apoE(-/-) mice. Arsenic decreased collagen content in the apoE(-/-) model, and we have observed the same diminution in LXRα(-/-)apoE(-/-) mice. However, the collagen-producing smooth muscle cells (SMCs) were decreased in apoE(-/-), but increased in LXRα(-/-)apoE(-/-). Although transcriptional activation of collagen remained the same in SMC from both genotypes, arsenic-exposed LXRα(-/-)apoE(-/-) plaques had increased matrix metalloproteinase activity compared with both control LXRα(-/-)apoE(-/-) and apoE(-/-), which could be responsible for both the decrease in plaque collagen and the SMC invasion. In addition, arsenic increased plaque lipid accumulation in both genotypes. However, macrophages, the cells known to retain lipid within the plaque, were unchanged in arsenic-exposed apoE(-/-) mice, but decreased in LXRα(-/-)apoE(-/-). We confirmed in vitro that these cells retained more lipid following arsenic exposure and are more sensitive to apoptosis than apoE(-/-). Mice lacking LXRα are resistant to arsenic-enhanced atherosclerosis, but arsenic-exposed LXRα(-/-)apoE(-/-) mice still present a different plaque composition pattern than the arsenic-exposed apoE(-/-) mice.

Indexed as

Gene DeletionAnimalsAortaApolipoproteins EApoptosisArsenitesAtherosclerosisCell ProliferationDisease Models, AnimalEnvironmental PollutantsLipid MetabolismLipidsLiver X ReceptorsMacrophagesMaleMice, KnockoutApolipoproteins EArsenitesEnvironmental PollutantsLipidsLiver X ReceptorsNr1h3 protein, mouseOrphan Nuclear Receptorssodium arseniteSodium CompoundsarsenicatherosclerosisLXRαmacrophagesMMP-9smooth muscle cells

Identifiers

PMID25273567
PMCPMC4250850
OpenAlexW2063436919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.